GlassScriptPhysician profile
William D Spielfogel
NPI 1790767093
$11,282.61
in general payments reported to CMS, 2019-2025
40 companies · $1,210 in 2025
The $1,210 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $806 · 2020: $743 · 2021: $4,399 · 2022: $1,394 · 2023: $1,434 · 2024: $1,297 · 2025: $1,210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,941.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,940.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Royal Biologics, INC. | $1,901.87 | 2020-2022 | |
| Gotham Surgical Solutions & Devices, INC. | $1,200.00 | 2021 | |
| Stryker Corporation | $1,027.26 | 2019-2025 | Ortholoc 3di, Variax, Gravity |
| Acera Surgical, INC. | $862.07 | 2022-2025 | Restrata Wound Matrix |
| Smith+Nephew, INC. | $708.10 | 2019-2025 | Grafix Pl, Collagenase Santyl |
| Polynovo North America LLC | $526.43 | 2024-2025 | Novosorb Btm |
| Zimmer Biomet Holdings, INC. | $446.77 | 2021-2023 | A.L.P.S., Incore Lapidus |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $432.43 | 2019-2023 | Jublia |
| Medshape, INC. | $409.64 | 2023-2024 | Dynanail Helix, Washer, 15 Mm, Dynaclip Bone Fixation System, Quattro, 22mm X 20mm X 20mm |
| Heron Therapeutics, INC. | $361.33 | 2021-2022 | |
| Gramercy Extremity Orthopedics LLC | $316.57 | 2021 | |
| Reddress USA, INC. | $295.75 | 2024-2025 | Actigraft |
| Novastep INC. | $263.12 | 2021-2024 | Nexis |
| Wright Medical Technology, INC. | $215.30 | 2020 | |
| Treace Medical Concepts, INC. | $214.15 | 2024-2025 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $196.10 | 2019-2020 | |
| Kerecis Limited | $192.14 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Horizon Therapeutics Plc | $180.18 | 2021-2022 | |
| Abbott Laboratories | $168.14 | 2024 | Proclaim |
| Grt US Holding, INC. | $163.16 | 2021-2022 | |
| Encore Medical, LP | $150.79 | 2022 | |
| Forma Medical | $126.16 | 2025 | Optimalmtp |
| Medtronic Vascular, INC. | $121.18 | 2019 | |
| Bioventus LLC | $119.83 | 2022 | |
| Merck Sharp & Dohme LLC | $78.61 | 2019 | |
| Misonix INC | $69.67 | 2021 | |
| Paratek Pharmaceuticals, INC. | $65.33 | 2020 | |
| Ossio INC | $64.11 | 2023 | |
| Nevro Corp. | $47.28 | 2022 | |
| Acell, INC. | $46.30 | 2019 | |
| Sebela Pharmaceuticals INC. | $45.58 | 2022-2023 | Naftin, Pramosone |
| Orthofix Medical, INC. | $44.46 | 2019 | |
| Baxter Healthcare | $39.52 | 2022 | |
| Organogenesis INC. | $36.35 | 2023 | Puraply |
| Polarityte, INC. | $33.44 | 2019 | |
| Nabriva Therapeutics, Plc | $28.76 | 2020 | |
| Alfasigma USA, INC. | $26.85 | 2021 | |
| Sanara Medtech INC. | $22.86 | 2023 | Celleraterx |
| Osiris Therapeutics INC. | $19.96 | 2019 | |
| Lilly USA, LLC | $15.06 | 2025 | Zepbound, Mounjaro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$700,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Spielfogel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.